Christopher David Snook
Direttore/Membro del Consiglio presso Sandoz Pharmaceuticals AG
Profilo
Christopher David Snook is currently a Director at Sandoz Pharmaceuticals AG and Alcon Canada, Inc. He was previously a Director and Head-Investor Relations at Pennant International Group Plc from 2000 to 2017.
Posizioni attive di Christopher David Snook
Società | Posizione | Inizio |
---|---|---|
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Direttore/Membro del Consiglio | - |
Alcon Canada, Inc.
Alcon Canada, Inc. Electronic ComponentsElectronic Technology Alcon Canada, Inc. engages in developing, manufacturing, and marketing eye care products and instrumentation. Its products include alcon surgical, alcon pharmaceutical and alcon vision care products. The company is headquartered in Mississauga, Canada. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Christopher David Snook
Società | Posizione | Fine |
---|---|---|
PENNANT INTERNATIONAL GROUP PLC | Amministratore Delegato | 21/02/2017 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PENNANT INTERNATIONAL GROUP PLC | Technology Services |
Aziende private | 2 |
---|---|
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Health Technology |
Alcon Canada, Inc.
Alcon Canada, Inc. Electronic ComponentsElectronic Technology Alcon Canada, Inc. engages in developing, manufacturing, and marketing eye care products and instrumentation. Its products include alcon surgical, alcon pharmaceutical and alcon vision care products. The company is headquartered in Mississauga, Canada. | Electronic Technology |
- Borsa valori
- Insiders
- Christopher David Snook